Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis

NCT01736150 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Chronic Kidney Disease on Hemodialysis

Interventions

DRUG: Placebo
DRUG: Sevelamer carbonate

Sponsor

Genzyme, a Sanofi Company